MAM
ROIV icon

Marquette Asset Management’s Roivant Sciences ROIV Stock Holding History

Marquette Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45K Sell
267
-17
-6% -$502 ﹤0.01% 321
2026
Q1 		$7.87K Buy
284
+74
+35% +$1.9K ﹤0.01% 289
2025
Q4 		$4.56K Hold
210
– – ﹤0.01% 340
2025
Q3 		$3.18K Buy
+210
New +$2.6K ﹤0.01% 420

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Marquette Asset Management's ROIV Position: Q2 2026 in Review

Marquette Asset Management reduced its Roivant Sciences (ROIV) stake by 6% in Q2 2026, selling an estimated $502 and leaving 267 shares worth $9.45K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

Marquette Asset Management first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 220 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Marquette Asset Management held 267 shares of Roivant Sciences worth $9.45K as of Q2 2026.
  • Marquette Asset Management sold 17 Roivant Sciences shares in Q2 2026, an estimated $502.
  • Roivant Sciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #321 holding.
  • Marquette Asset Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 220 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.